data

Union Minister for Communications launches Tejas Networks’ hyper-scalable Data Center Interconnect (DCI) platform at Mobile World Congress

BENGALURU, India and BARCELONA, Spain, March 4, 2026 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE: TEJASNET) today announced the launch of…

14 hours ago

Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity

-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142) at 52 weeks, including 12 Japanese patients and…

3 days ago

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting

Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026…

4 days ago

Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting

February 28, 2026 09:45 ET  | Source: Cogent Biosciences, Inc. Bezuclastinib mean TSS reduction deepens to –32.0 points at 48…

4 days ago

Crisil launches i360, a unified, GenAI-led research, data and analytics platform

Largest integrated portal enabling sharper, faster decisions via seamless macro-to-micro coverageMUMBAI, India, Feb. 27, 2026 /PRNewswire/ -- Crisil today rolled…

5 days ago

Ataccama Launches Agentic Data Observability to Extend Market-Leading Data Trust Platform

BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ataccama, the data trust company, today announced Agentic Data Observability in Ataccama ONE,…

6 days ago

Supermicro and VAST Data Launch a New Enterprise AI Data Platform Solution with NVIDIA to Accelerate AI Factory Deployment

Platform brings high-performance compute, scalable data infrastructure, and intelligent software together as one ready-to-run solution.Fully integrated AI infrastructure stack includes…

7 days ago

NYSE Content Update: AI Data Platform DDN Appoints Guido Torrini as Finance Chief

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 24, 2026 /PRNewswire/ -- The New York…

1 week ago

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026

February 23, 2026 17:10 ET  | Source: Kyntra Bio FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen…

1 week ago